News & Updates

Follows our journey in developing the best therapeutics for patients with EBV-associated malignancies

ACE NanoMed Selected for Prestigious Incu-Bio Program at HKSTP

ACE NanoMed is excited to announce its selection to participate in the renowned Incu-Bio program at the Hong Kong Science and Technology...

Groundbreaking Development: Innovative mRNA Drug for Nasopharyngeal Cancer

Professor K.W. Lo and Professor Anna Tsang, together with some industry experts and collaborators, hosted a press conference organized by...

Professor K.W. Lo and Professor Anna Tsang of ACE NanoMed win Silver Medals at the 49th International Exhibition of Inventions Geneva 2024

ACE NanoMed, a leading drug research and development company, is proud to announce that Professor K.W. Lo and Professor Anna Tsang,...

ACE NanoMed Limited: Revolutionizing Cancer Treatment With Innovative Drug Solutions

ACE NanoMed, A Biomedical Company Specializing In The Development Of Advanced Therapies For Cancers Associated With The Epstein-Barr...

ACE NanoMed Limited Emerges As Champion In CUHK Innovation Day 2023'S Elevator Pitch Competition

ACE NanoMed Limited, A Leading Innovator In The Field Of Nanomedicine, Emerged As The Champion Of The CUHK Innovation Day 2023'S Elevator...